VolitionRX News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.09.17	Volition Granted Four Additional Patents (PR Newswire)
06.09.17	VolitionRx Limited to Attend Multiple Conferences in September (PR Newswire)
22.08.17	Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers (PR Newswire)
09.08.17	VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update (PR Newswire)
03.08.17	VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update (PR Newswire)
19.07.17	VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute (PR Newswire)
18.07.17	Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer... (PR Newswire)
30.06.17	Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress (PR Newswire)
27.06.17	VolitionRx Limited Corrects an Earlier Announcement (PR Newswire)
18.05.17	A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays (PR Newswire)
11.05.17	VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update (PR Newswire)
09.05.17	VolitionRx Limited Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate the Performance of its Nu.Q(TM) Triage Test (PR Newswire)
27.04.17	Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe (PR Newswire)
21.04.17	Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory (PR Newswire)
11.04.17	VolitionRx Appoints David Vanston as Chief Financial Officer (PR Newswire)
28.03.17	Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States (PR Newswire)
20.03.17	VolitionRx Limited Announces the Formation of Volition America, Inc. (PR Newswire)
14.03.17	VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange (PR Newswire)
13.03.17	VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time (PR Newswire)
10.03.17	VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update (PR Newswire)
08.03.17	VolitionRx Limited to Present at the 29th Annual ROTH Conference (PR Newswire)
06.03.17	VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update (PR Newswire)
02.03.17	A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark (PR Newswire)
23.02.17	VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference (PR Newswire)
09.02.17	VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017 (PR Newswire)
05.01.17	VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia (PR Newswire)
03.01.17	VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe (PR Newswire)
28.12.16	VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference (PR Newswire)
01.12.16	VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference (PR Newswire)
26.09.13	VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits (PR Newswire)
22.07.13	VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu VolitionRX Ltd

Aktien Top/Flop

Meistgelesene Nachrichten